OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study

Souza, Fátima Cleonice de; Mocellin, Magáli; Ongaratto, Renata; Leitão, Lidiane Alves de Azeredo; Friedrich, Frederico Orlando; Silveira, Victória d'A; Scotta, Marcelo Comerlato; Pitrez, Paulo Márcio; Pinto, Leonardo Araújo.
Einstein (Säo Paulo) ; 18: eAO5262, 2020. tab
Artículo en Inglés | LILACS | ID: biblio-1090059

Documentos relacionados

  1. Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial.
  2. OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study.
  3. Mechanical bacterial lysate administration prevents exacerbation in allergic asthmatic children-The EOLIA study.
  4. [Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection].
  5. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections.
  6. ADAPTIVE MECHANISMS OF THE IMMUNE SYSTEM IN CHILDREN IN FAR NORTH.
  7. Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease.
  8. Bacterial lysate increases the percentage of natural killer T cells in peripheral blood and alleviates asthma in children.
  9. Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study.
  10. [Bacterial lysates: history and availability].